In line with the WHO Essential Diagnostics List (EDL) and Lancet Commission efforts, the Asia Pacific Medical Technology Association and its members recently came together to produce an inaugural paper about the value delivered by diagnostic technologies in the Asia Pacific region. This session covers the latest insights from public-private dialogue on improving the value recognition of diagnostic technologies by governments and payers in the region, using live case studies to demonstrate the potential for a shared journey toward sustainable population health.